How much funding has Chaperone Therapeutics raised?

Chaperone Therapeutics has disclosed $456.6K raised across 1 round.

Where is Chaperone Therapeutics headquartered?

Chaperone Therapeutics is headquartered in Chapel Hill, US.

Chaperone Therapeutics

Chapel Hill, US · Delaware corporation

Find your way into Chaperone Therapeutics

Chaperone Therapeutics develops therapies targeting protein misfolding diseases, including neurodegenerative and rare conditions, using small molecule drug discovery platforms that enhance natural protein folding mechanisms.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Kalpana MerchantExecutive

Dennis ThieleNamed on SEC filing

Maria Sippola-ThieleNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$456.6K disclosed across 1 round · 2016

▶$456.6KraisedJan 2017 · 5 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kalpana MerchantExecutive Officer
Dennis ThieleExecutive Officer, Director
Maria Sippola-ThieleExecutive Officer, Director, Promoter

Offering amount: $900K
Amount sold: $456.6K
First sale: Dec 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Bionity3 shared keywordsBionity.com is a German-language B2B trade portal for the life sciences, biotechnology, and pharmaceutical industries, offering news, trends, supplier directories, job listings, and lab and production solutions. Operated by LUMITOS AG, it serves professionals in industry, research, and science and provides online marketing services to reach this B2B audience.

Companies competing with Chaperone Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2017	$3M
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2016	$270K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Chaperone Therapeutics do?: Chaperone Therapeutics develops therapies targeting protein misfolding diseases, including neurodegenerative and rare conditions, using small molecule drug discovery platforms that enhance natural protein folding mechanisms.
How much funding has Chaperone Therapeutics raised?: Chaperone Therapeutics has disclosed $456.6K raised across 1 round.
Where is Chaperone Therapeutics headquartered?: Chaperone Therapeutics is headquartered in Chapel Hill, US.